(Recorded on January 20, 2015)
Dotmatics has developed a suite of informatics tools that facilitates registration, data entry, retrieval and analysis to support a wide range of disciplines and functions. These are presented in a web-based environment geared towards sharing live data securely.
- An overview of the Dotmatics Platform
- How to use web and cloud-based technologies to facilitate secure data exchange across different business functions, institutions and geographies
- Case Study: AstraZeneca Neuroscience – discover how a large pharmaceutical company uses Dotmatics to manage their collaborations with universities, CROs and other departments across their own organisation
Who Should Attend:
- Research and Development
- Pharmaceutical Research
Moderator – Biographies/Introductions
Jeremy Major, Dotmatics - Maximising the use of modern technology to facilitate real-time collaborative research
Roland Bürli, AstraZeneca – Using the Dotmatics Platform to facilitate external collaborations
Moderator – Questions
Dr Roland Bürli, PhD, Project Director, Neuroscience iMED Roland.Burli@azneuro.com
Roland Bürli brings 17 years of post-graduate experience in Medicinal Chemistry and Preclinical Drug Discovery. In industry, he worked at Genesoft, a startup biotech in South an Francisco, and later joined Amgen, Thousand Oaks, where he led early and late-stage projects across carious therapeutic areas. In 2008, he joined BioFocus, a UK-based CRO, where he initiate and led several collaborations; of particular significant is the collaboration with CHDI aiming at a therapy for Huntington’s disease. Roland studied Chemistry and obtained his PhD at the ETH, Zürich, followed by Post-Doctoral work at Caltech, Pasadena. He has co-authored over 70 scientific publications and patents. Roland is now working within the AstraZeneca Neuroscience iMED and is located at MedImmune, Granta Park.
Dr Jeremy Major,BSc and PhD in Chemistry from the University of Leeds, Application Science Team Leader, Application Science, Dotmatics Jeremy.Major@dotmatics.com
Jeremy obtained his degree and PhD in Chemistry from the University of Leeds then worked as a medicinal chemist at Millennium Pharmaceuticals. More recently as Associate Director of Medicinal Chemistry at Cellzome Ltd, Jeremy led project teams from project onset through to pre-clinical development. He managed the computational chemistry team where he was responsible for streamlining data management and improving data visualisation capabilities. Jeremy joined Dotmatics in 2013, bringing over 12 years’ experience working on kinase, secretase and epigenetic targets in the areas of oncology, neurodegeneration and auto-immune disease.